|
|
Article: Primary raising's mixed prognosis.
- Article from:
- Australasian Business Intelligence
- Article date:
- March 10, 2008
CopyrightCOPYRIGHT 2008 News provided by Comtex. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
Byline: Teresa Ooi
Mar 10, 2008 (The Australian - ABIX via COMTEX) -- Australian private hospitals management group Primary Health Care is trying to source $A1.23bn in new capital. It needs to fund the $A2.7bn takeover of Symbion Health, the diagnostic and pharmaceutical services company. However, at a share price for Primary on 10 March 2008 of $A5.07 after a fall of $A0.13 for the day, investors will find the share issue unattractive at a price of $A5.40 per entitlement. The ultimate losers will be the lead underwriters ABN AMRO, Credit Suisse and Deutsche Bank. Sigma Pharmaceuticals as well as private equity firms Pacific Equity Partners, Ironbridge and Archer ...